|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001383,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0033684,
umls-concept:C0178539,
umls-concept:C0205460,
umls-concept:C0206293,
umls-concept:C0221099,
umls-concept:C0871261,
umls-concept:C1412581,
umls-concept:C1538881,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1825497,
umls-concept:C1948023,
umls-concept:C2698872,
umls-concept:C2911692
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1998-12-17
|
|
pubmed:abstractText |
The objective of this study was to examine specific membrane binding of [125I]-acylation stimulating protein (ASP) in cultured human skin fibroblasts obtained from normal subjects and patients with hyperapoB. ASP is a small basic protein isolated from human plasma that stimulates triglyceride synthesis (TGS) and glucose transport (GT) in human skin fibroblasts and adipocytes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0014-2972
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
730-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9767372-Adult,
pubmed-meshheading:9767372-Aged,
pubmed-meshheading:9767372-Apolipoproteins B,
pubmed-meshheading:9767372-Binding, Competitive,
pubmed-meshheading:9767372-Biological Transport, Active,
pubmed-meshheading:9767372-Blood Proteins,
pubmed-meshheading:9767372-Cell Line,
pubmed-meshheading:9767372-Complement C3a,
pubmed-meshheading:9767372-Female,
pubmed-meshheading:9767372-Fibroblasts,
pubmed-meshheading:9767372-Glucose,
pubmed-meshheading:9767372-Humans,
pubmed-meshheading:9767372-Hyperlipoproteinemias,
pubmed-meshheading:9767372-Insulin,
pubmed-meshheading:9767372-Male,
pubmed-meshheading:9767372-Middle Aged,
pubmed-meshheading:9767372-Tetradecanoylphorbol Acetate,
pubmed-meshheading:9767372-Triglycerides
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.
|
|
pubmed:affiliation |
Laboratory for Cardiovascular Research, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
